antisense oligomers in the culture media. Taken together, these observations show that the proto-oncogenes which encode forfosUun transcription factors play important roles in promoting myeloid differentiation. The ability of the Ml leukemic myeloblasts to be induced for terminal differentiation in the absence of apparentfos expression indicates that there is some redundancy among the fosUun family of transcription factors in promoting myeloid differentiation; however, juns alone cannot completely compensate for the lack offos. Thus, genetic lesions affecting fosUun expression may play a role in the development of "preleukemic" myelodysplastic syndromes and their further progression to leukemias.
Growth and differentiation of animal cells is a wellcontrolled and highly conserved process involving multiple changes in gene expression that are developmentally regulated and result in the conversion of proliferating, undifferentiated cells into nonproliferating, highly specialized cells. A profound example of this process, which continues throughout life, is the complex blood cell formation, whereby a hierarchy of hematopoietic progenitor cells in the bone marrow proliferate and differentiate along multiple, distinct cell lineages, including the proliferation and differentiation of myeloid precursor cells into mature granulocytes and macrophages (57) . The establishment of in vitro culture systems for the clonal development of bone marrow cells (6, 43) and the availability of Ml myeloblastic leukemia cells, which proliferate autonomously and can be induced for differentiation and loss of leukemogenicity by physiological myelopoietic factors (15, 47, 49) , provide an excellent biological system with which to study, side by side, the molecular biology of normal blood cell development and lesions that afflict it in leukemia and upon its progression (20, 23, 29, 30) .
To enhance our understanding of the regulation of normal terminal differentiation and alterations in these regulatory processes that block differentiation, leading to leukemogenicity and its progression, recently we isolated and charac-terized cDNA clones of myeloid differentiation primary response (MyD) genes (1, (32) (33) (34) (35) (36) . MyD genes are activated in the absence of de novo protein synthesis in Ml cells following induction for terminal differentiation and growth arrest by conditioned medium of mouse lungs (LUCM), a potent physiological source of hemopoietic differentiation inducers (29, 50) . These studies have led to the conclusion that the immediate-early genetic response of terminal myeloid differentiation is complex. Both known genes, previously identified in the context of other biological systems, and novel genes, with yet unknown functions, are induced (1, 2, (32) (33) (34) (35) (36) . In the course of this work, the proto-oncogenes c-jun, junB, and junD were identified as MyD genes, which are stably induced, suggesting that they may play key roles in the initiation, progression, and maintenance of the myelopoietic differentiation program.
The proto-oncogenes c-jun, junB, junD, and c-fos recently have been shown to encode proteins with a leucine zipper that mediates dimerization to constitute active transcription factors; juns were shown to dimerize with each other and with c-fos, whereas fos was shown to dimerize only with juns (44, 56) . After birth, hematopoietic cells of the myeloid lineage (reference 13 and references; 29) and some other terminally differentiated cell types (51) express high levels of c-fos. However, the role of fos/jun transcription factors in normal myelopoiesis or in leukemogenesis has not been established. Intriguingly, c-fos, though stably induced during normal myelopoiesis, was not induced upon Ml differentia-842 LORD ET AL. tion (29, 32) . To gain further insights into the role of fosijun in normal myelopoiesis and leukemogenicity, Ml cells were stably transfected with a c-fos or junB transgene (junB was chosen as a paradigm for afosijun gene similarly induced in both Ml and normal myeloblasts), to obtain Mlfos and MljunB cell lines that constitutively express c-fos or junB, and their growth and differentiation properties were analyzed. In addition, the effect of constitutive expression of c-fos on leukemogenicity of Ml cells in vivo was analyzed. The results of these experiments indicate that the protooncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation.
MATERIALS AND METHODS
Cells, cell culture, and mice. The murine Mi myeloid leukemic cell line, obtained from E. R. Stanley (Albert Einstein College of Medicine), was recloned in soft agar; clones were tested for differentiation-associated properties as described previously (29, 32, 34) . Ml differentiationcompetent clone 9 (M1D+) was used in this study. Myeloblast-enriched bone marrow cells were obtained from femurs of CD-1 mice (Charles River Laboratories) injected intraperitoneally 3 days earlier with 3 ml of 10% sodium caseinate (Difco) in phosphate-buffered saline (PBS) (29 (29) .
Cytokines, biologicals, and other compounds. Serum-free LUCM was prepared with LiCl (24) and used at a concentration of 10%. Purified human recombinant interleukin-6 (IL-6) (0.5 mg/ml) was a gift from L. Souza, Amgen, Inc., Thousand Oaks, Calif., and used at a concentration of 100 ng/ml. Purified murine leukemia-inhibitory factor (106 U/ml), obtained from AMRAD Corp., Victoria, Australia, was used at a concentration of 200 U/ml. Purified recombinant granulocyte colony-stimulating factor (G-CSF) was a gift from Amgen and was used at a concentration of 160 ng/ml. Macrophage colony-stimulating factor (M-CSF) from serumfree conditioned medium of L929 fibroblasts, concentrated 100-fold by using high-molecular-weight polyethylene glycol (Serva), or purified M-CSF was used at 100 U/ml. The cytokines were titrated for differentiation-inducing and growth-inhibitory activities as described previously (22, 29, 34) . Experiments were conducted by using concentrations which represent the optimum of the linear differentiation and/or growth inhibition dose-response curves.
The phosphorothioate-capped antisense oligonucleotide (5'-AsAsACCCGAGAACATCsAsT-3'), targeted against the first five codons plus two additional bases of c-fos (55) Assays for differentiation-associated properties. Fc and C3 receptors were assayed as previously described (32, 37) . Cell attachment was determined as previously described (32 (5, 21) . Probes for c-fos, 0-actin, and IL-6 were the same as those used previously (29, 33) . The probe forfosB was the 2-kb EcoRI insert of cDNA clone AC113-1, kindly provided by Rodrigo Bravo (58) , whereas the probe for firal was the 1.5-kb insert of cDNA clone pSP65-fral (11) , a kind gift of Donna Cohen. DNA for probes was labeled by random priming to a specific activity equal to or greater than 109 cpm/,ig (14) .
c-fos andjunB expression vectors. pCMV-fos, in which rat c-fos is under control of the cytomegalovirus (CMV) immediate-early promoter (52) (7), the 21-mer primers used spanned positions 388 to 408 and 617 to 597. After extraction with CHC13, 20 ,ul of products was electrophoresed, blotted, and hybridized with the IL-6 probe excised from pSP6mifB (32) . A DNA with appropriate primers (Perkin-Elmer Cetus) was used as an internal marker to monitor for efficiency and reproducibility of PCR amplification, and control samples not reverse transcribed were used to monitor for possible contamination with genomic DNA. RT-PCR for quantitation of c-fos with a low number of cells (<106; as in the case of antisense experiments) was performed essentially as indicated above except that RNA was extracted in the presence of 20 ,ug of E. coli rRNA (Boehringer Mannheim) per ml and subjected to 14 cycles of amplification. The 24-mer primers used correspond to nucleotides 205 to 228 and 645 to 622 for c-fos (rat/mouse) RNAs (12, 55) . In all cases, PCR analysis, as determined empirically, was within the linear range of PCR cycles for IL-6 or fos mRNA. For quantitation of PCR products, films were exposed for periods during which band intensity was linear with respect to time, and relative intensities of hybridization A. signals were measured at 560 nm with the gel scan program of a Beckman DU7 spectrophotometer.
RESULTS
fosUun expression upon induction of differentiation of Ml leukemic myeloblasts compared with normal myeloblasts. We have shown that LUCM is a potent physiological source of myelopoietic differentiation inducers, including IL-6 (33, 50), which can be used to induce differentiation of Ml leukemic myeloblasts as well as normal myeloblast-enriched bone marrow cells (29) . LUCM induces primarily macrophage differentiation in Ml cells and both macrophage and granulocyte differentiation in normal myeloblasts (29) . As shown in Fig. 1A , both jun (c-jun, junB, and junD) and fos mRNAs were stably expressed during LUCM-induced differentiation of normal myeloblasts. Further analysis of normal myeloid cells showed that fos/jun mRNAs were stably expressed upon induction of either granulocyte or macrophage differentiation, using G-CSF and M-CSF, respectively (Fig. 1B) . In contrast, only jun (c-jun, junB, and junD) mRNAs were expressed during Ml differentiation induced by either LUCM or purified IL-6 (Fig. 1 ). G-CSF and M-CSF, which do not induce Ml differentiation (29) , also did not induce fos/jun in Ml cells (data not shown). pAc.junB, respectively ( Fig. 2A) , as described in Materials and Methods. As shown in Fig. 2B , Mlfos and MljunB cell lines expressed c-fos and junB mRNAs, respectively, whereas no expression was observed in parental Ml cells prior to stimulation with IL-6. Expression of c-fos or junB was not detected in Ml transfectants obtained by using a vector carrying the selectable marker only (Mlneo). DNAs obtained from the transfectants contained c-fos-or junBhybridizing fragments characteristic of the transfecting vectors (data not shown). Following induction of differentiation with IL-6, expression of c-fos in Mlfosl4 was maintained at similar levels at early as well as at late times, whereas expression of exogenous junB RNA (under control of the ,-actin promoter) in MljunB9 increased slightly (Fig. 2C) . Similar results were obtained with other Mlfos and MljunB cell lines. It should be pointed out that only Mlfos cell lines expressing lower levels offos than did normal cells could be established, even when an expression vector containing the strong ,B-actin promoter was used; 8-to 12-fold-lower levels of fos RNA (quantitated by densitometry) and much lower levels of fos protein (assessed by indirect immunofluorescence [42] ) were observed in Mlfos cells than in terminally differentiated normal myeloid cells (e.g., granulocytes and macrophages).
It was demonstrated that c-fos greatly enhances binding of the different jun proteins to the tetradecanoyl phorbol acetate-responsive element (TRE) (AP-1) consensus sequences (41, 46) and enhances transactivation compared with jun only (40) . Also, it was shown that TRE-containing promoters are largely unresponsive to junB and can be activated by the other juns and that junB inhibits transactivation of TRE promoters (8, 40) . Thus, transactivation of the TRE col/TK promoter (with the thymidine kinase [TK] promoter fused to a synthetic consensus TRE sequence [3] ) was used to ascertain the functionality of the c-fos and junB transgenes. This was done by measuring chloramphenicol acetyltransferase (CAT) activity following transient transfection of plasmid TRE colFIK-CAT into Ml, MljunB and Mlfos cell lines. As shown in Fig. 2D , transactivation of the TRE col/TK promoter was relatively low in untreated Ml cells and slightly higher following stimulation with optimal concentrations (100 ng/ml) of IL-6. Transactivation of the TRE col/T1K promoter was lower in MljunB cells than in Ml cells, both untreated and following stimulation with IL-6, which is consistent with a functional junB transgene. Apparently, in unstimulated MljunB cells, the protein product of the junB transgene can compete with proteins from endogenous jun genes, which are expressed at low basal levels (notably junD; Fig. 1 Fig. 2D , also was observed with two other MljunB (11, 27) (22, 24) and MljunB (11, 27) cell lines (Fig. 2B) were essentially the same as described below for Mlfosl4 and MljunB9 cell lines, respectively.
As shown in Fig. 3A , constitutive expression of c-fos and to a lesser extent junB had a dramatic effect on growth arrest associated with Ml terminal differentiation induced by IL-6. 3B) . Proliferation of all of these cell lines was inhibited, however, by IL-6 at 100 ng/ml (Fig. 3A and B) , the optimal concentration for Mi-induced differentiation. Consistent with the proliferative capabilities of the cells in mass culture, at 1 ng of IL-6 per ml, the relative cloning efficiency of Ml cells in soft agar was enhanced, whereas the cloning efficiency of Mlfos cells decreased dramatically; colony formation of all of these Ml cells was inhibited by 100 ng of IL-6 per ml (Table 1 and Fig. 4A ).
Furthermore, it was observed that in the absence of IL-6, a significant number (-25%) of the colonies formed by Mlfos cells displayed a diffuse morphology at 7 days (Fig.  4B) , characteristic of colonies with differentiated myeloid cells (31) ; the majority of these colonies degenerated by 14 (Fig. 5A ). In the case of Mlfos, the majority of these cell aggregates attached to the surface of the tissue culture plate. It should be pointed out that aggregation is an early differentiation-associated characteristic of Ml cells (34) . It also was observed that Mlfos cells were induced for macrophage differentiation associated with attachment of the cells to the surface of the tissue culture plate with 1 ng of IL-6 per ml, which did not induce macrophage differentiation and cell attachment of Ml or MljunB cells (Table 1 and Fig.  5A and B) . This result is consistent with the colony morphology seen in Fig. 4B .
Fc and C3 receptors are early myeloid differentiation markers that start to appear at about 6 h, following induction of differentiation of Ml cells and continue to increase (Fig.  6 ). As shown in Table 1 and Fig. 6 increase was observed with Mlfos cells (216%). It was also observed that at low concentrations of IL-6 (1 ng/ml), the number of Mlfos cells which displayed Fc and C3 receptors was significantly higher than the number of Ml and MljunB cells ( Table 1 ). The optimal concentration of IL-6 (100 ng/ml) induced similar high numbers of cells displaying Fc and C3 receptors in all three cell lines following 3 days (Table 1) ; however, the kinetics of induction of Fc and C3 receptors was accelerated in MljunB and Mlfos cells compared with Ml cells (Fig. 6) (MyD32 [1] ), and MyD88, a novel MyD gene whose sequence has been reported recently (35) . We have also looked at the effects of constitutive expression of c-fos or junB on two late genetic markers associated with Ml myeloid differentiation, namely, the ferritin light chain and lysozyme (21, 26) .
As shown in Fig. 7A , stimulation of Ml cells with a low concentration of IL-6 (1 ng/ml) stably induced c-jun and junD mRNAs, although induction of c-jun mRNA was lower than what was observed with the optimal concentration (100 ng/ml) of IL-6. However, junB, IRFI, and MyD88 mRNAs were only transiently induced, unlike the stable induction observed following stimulation with 100 ng of IL-6 per ml. In contrast, stimulation of Mlfos cells with 1 ng of IL-6 per ml was sufficient to muster stable induction of all MyD gene As shown in Fig. 7B , in Ml cells, ferritin light-chain mRNA was induced following 1 day of stimulation with either 1 or 100 ng of IL-6 per ml; however, stable expression was observed only at the optimal IL-6 concentration (100 ng/ml). Induction of lyzozyme mRNA in Ml cells was observed 3 days following stimulation of the cells with 100 ng of IL-6 per ml, and no induction was detected with 1 ng/ml.
In contrast, Mlfos cells constitutively expressed high levels of both ferritin light-chain and lysozyme mRNAs, and ferritin transcript levels were further increased following stimulation with IL-6. Interestingly, in the case of lysozyme expression, it was observed reproducibly that in Mlfos cells, the level of mRNA increased following stimulation with 1 but not 100 ng of IL-6 per ml (Fig. 7B) ; an analogous observation may be that the level of lysozyme mRNA was much lower following stimulation of Ml cells with supraoptimal concentrations (2500 ng/ml) of IL-6 compared with stimulation with the optimal concentration (100 ng/ml) (data not shown). Again, in MljunB cells, expression of these late genetic markers did not vary significantly compared with what was observed in Ml cells, except that induction of lysozyme mRNA was higher in MljunB cells than in Ml cells following treatment with IL-6 at 100 ng/ml (Fig. 7B) .
Effects of antisense c-fos oligomers on the differentiation of normal myeloblasts and Mlfos leukemic myeloblasts. Expression of c-fos was observed to be induced upon induction of macrophage or granulocyte differentiation in normal bone marrow-derived myeloblasts (Fig. 1B) . It was also observed that constitutive expression of c-fos in Ml leukemic myeloblasts dramatically increased the propensity of the cells to be induced for terminal differentiation by To further assess the role of c-fos in myeloid cell development, we examined the effects of c-fos antisense oligodeoxynucleotides (oligomers) in the culture medium on the differentiation of normal and the Mlfos leukemic myeloblasts.
As shown in Fig. 8A and C, stimulation of myeloblastenriched bone marrow cells with M-CSF or G-CSF, in the presence of control sense oligomers, resulted in differentiation of the majority of the cells into macrophages or granulocytes, respectively, similar to what was observed in the absence of oligomers (not shown). In contrast, in the presence of c-fos antisense oligomers, the number of mature macrophages or granulocytes was significantly reduced, and the number of myeloblasts was significantly increased.
Similar experiments with Mlfos cells have shown (Fig.   8A ) that in the absence of IL-6, neither sense nor antisense c-fos oligomers had a marked effect on the growth and differentiation properties of the cells, except that proliferation of Mlfos cells treated with antisense oligomers appeared, reproducibly, to be slightly enhanced compared with their proliferation in the presence (or absence) of c-fos sense oligomers (Fig. 8A) . However, the ability of the Mlfos cells to be induced for differentiation with a low concentration of IL-6 was observed to be markedly impaired in the presence of c-fos antisense oligomers compared with sense oligomers, as evident from the lower number of mature macrophagelike cells and concomitant increase in the number of myeloblasts (Fig. 8A) . Neither c-fos sense nor antisense oligomers had any effect on the proliferation or differentiation of Ml cells (data not shown). As shown in Fig. 8B , treatment of bone marrow or Mlfos myeloblasts with c-fos antisense, but not sense, oligomers (at the same concentration that was used in the experiments described above) also reduced c-fos RNA.
Taken together, these observations provide further evidence for the important role that proto-oncogenes of the fos/jun family play in myeloid cell development (keeping in mind thatfos must dimerize withjun to constitute functional transcription factors [44, 56] ) and further substantiate the notion of the role that enforced expression of a c-fos transgene in Ml cells plays in increasing the propensity of these leukemic myeloblasts to be induced for differentiation by Constitutive expression of c-fos decreases the leukemogenicity of Ml cells. Ml cells are leukemogenic when injected into syngeneic (SL) or nude mice, and their leukemogenicity is lost following induction of differentiation in vitro or in vivo (47, 49) . Thus, it is important to understand the relationship between an increase in the propensity of Mlfos cells to be induced for differentiation in vitro and their leukemogenicity in vivo.
As shown in Fig. 9 As shown in Fig. 10 (27, 28) , thereby suggesting that they may play a role in the initiation, progression, and maintenance of the differentiation program. We would like to point out that expression of the RNA of neitherfosB (58) nor fral (11) , two fos-related genes, was detectable in the Ml cells used in this study or in myeloid-enriched bone marrow cells. More recently, the isolation of a third distinct fos-related gene, termed fra2 (38) , has been documented.
Whether the product of this gene plays a role in myeloid differentiation remains to be determined.
Mlfos cells, which constitutively express a c-fos transgene, were shown to have a dramatically greater propensity to be induced for terminal differentiation by IL-6 than did Ml cells, which do not express fos during differentiation. Low levels of IL-6 were sufficient to muster stable induction of a set of immediate-early MyD genes in Mlfos but not in Ml cells, including MyD genes regulated at the transcriptional or posttranscriptional levels (33) . Also, Mlfos cells constitutively express genetic markers of Mi-induced differentiation, including the immediate-early genetic markers c-jun, junB, and IRFI, the early marker IL-6, and the late genetic markers ferritin and lysozyme. The differentiation of normal myeloblasts in vitro into mature macrophages or granulocytes, as well as the increased propensity of Mlfos leukemic myeloblasts to be induced for terminal differentiation, was dramatically impaired via the use of c-fos antisense oligomers in the culture media. Finally, Mlfos cells were shown to display a less aggressive leukemic phenotype than did the parental Ml cells when injected into nude mice. Taken together, these observations clearly provide the first evidence of an important role for proto-oncogenes of the fos/jun family of transcription factors, notably c-fos, in the control of hematopoietic cell differentiation. To what extent all of these characteristics of the Mlfos cells reflect either the direct function of fos/jun transcription factors or an indirect function, further down the ladder of the fos/jun regulatory cascade, remains to be determined.
The ability of the Ml leukemic myeloblasts to be induced for terminal differentiation in the absence of apparent fos expression indicates that there is some redundancy among the fos/jun family of transcription factors in promoting myeloid differentiation; however, the juns alone cannot completely compensate for the lack of fos. Thus, genetic lesions affecting fos/jun expression may play a role in the development of "preleukemic" myelodysplastic syndromes and their further progression to leukemias.
Recently, by using a transgenic mouse line containing a fos-lacZ fusion gene, high constitutive levels of fos-lacZ were observed in skin, hair follicle, and bone, suggesting that constitutive expression of c-fos is associated with terminal differentiation of other cell types as well (51) . Involvement of other leucine zipper transcription factors, e.g., transcription factors of the C/EBP family, in terminal differentiation of adipocytes has been demonstrated recently (54) . By using this cellular system, it also was shown that constitutive expression of c-myc prohibited the induction of C/EBPa and prevented adipogenesis and that enforced expression of C/EBPa overcame the myc-induced block of adipocyte differentiation (17) .
Clearly, further genetic manipulation of Ml cells as well as Mlmyc and Mlmyb cells, recently established in our laboratory, in which the genetic program of myeloid maturation has been disrupted at distinct developmental stages (21, 49) , will be carried out. This analysis will be instrumental in determining the molecular nature and functions of different hetero-and homodimer transcription factor complexes of the fos/jun family in the initiation, progression, and maintenance of the normal myeloid differentiation program and the type of lesions that may afflict the function of these genes, thereby playing a role in leukemogenesis and its progression.
